Immunosuppressive activity of recombinant ILT3

George Vlad1, Zhuoru Liu, Qing-Yin Zhang

  • 1Department of Pathology, Columbia University, 630 West 168th Street, P and S 14-401, New York, NY 10032, USA.

Summary

Tolerogenic antigen presenting cells (APC) utilize inhibitory receptors ILT3 and ILT4. Engineered mutants reveal ILT3

Related Concept Videos